News
TECH
72.47
+0.14%
0.10
Weekly Report: what happened at TECH last week (0914-0918)?
Weekly Report · 19h ago
Is Bio-Techne (TECH) Reasonable On Cash Flow Or Too Rich?
Simply Wall St · 5d ago
Bio-Techne Supplements Merger Proxy Amid Shareholder Litigation
TipRanks · 09/14 21:35
Weekly Report: what happened at TECH last week (0907-0911)?
Weekly Report · 09/14 09:38
Why Is Techne (TECH) Down 0.1% Since Last Earnings Report?
NASDAQ · 09/11 15:30
Weekly Report: what happened at TECH last week (0831-0904)?
Weekly Report · 09/07 09:35
Bio-Techne (TECH), What Is Behind The Latest Attention?
Simply Wall St · 09/02 12:23
Bio-Techne Announces SBTi Validation Of 70% Scope 1 & 2 Emissions Reduction Target By FY2031 And Supplier Engagement Commitment, Reporting Significant Operational Emissions Cuts In FY2026
Benzinga · 09/01 10:36
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
PR Newswire · 09/01 10:30
Weekly Report: what happened at TECH last week (0824-0828)?
Weekly Report · 08/31 09:38
Trump Trade: U.S. considering new semiconductor tariffs
TipRanks · 08/27 14:06
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2026 Update
Seeking Alpha · 08/27 01:53
Bio-Techne’s Restrictive Merger Terms and Heavy Termination Fee Threaten Competitive Bidding and Future Deal Leverage
TipRanks · 08/26 06:00
1 Surging Stock for Long-Term Investors and 2 That Underwhelm
Barchart · 08/26 02:42
Weekly Report: what happened at TECH last week (0817-0821)?
Weekly Report · 08/24 09:38
1 Profitable Stock to Own for Decades and 2 We Turn Down
Barchart · 08/24 01:38
Bio-Techne (TECH) Stock Could Be 26% Overvalued On Growth Hopes
Simply Wall St · 08/23 04:30
TECH Stock Alert: Halper Sadeh LLC is Investigating Whether Bio-Techne Corporation is Obtaining a Fair Price for its Shareholders
Barchart · 08/22 03:43
Is Bio-Rad a Buy as Digital PCR Growth Meets a Premium Valuation?
NASDAQ · 08/21 14:31
Is Wall Street Bullish or Bearish on Bio-Techne Stock?
Barchart · 08/18 04:50
More
Webull provides a variety of real-time TECH stock news. You can receive the latest news about Bio-Techne Corp through multiple platforms. This information may help you make smarter investment decisions.
About TECH
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.